new_adrs_0322_1335|TRDA|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_adrs_0322_1335|TRDA|Long Name|1|1|Entrada Therapeutics Inc Total Current Assets (Quarterly) (USD)|Entrada Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Entrada Therapeutics Inc Inventories (Quarterly) (USD)|Entrada Therapeutics Inc Net PP&E (Quarterly) (USD)|Entrada Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Entrada Therapeutics Inc Total Liabilities (Quarterly) (USD)|Entrada Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Entrada Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Entrada Therapeutics Inc Total Deposits (Quarterly) (USD)|Entrada Therapeutics Inc Book Value (Quarterly) (USD)|Entrada Therapeutics Inc Retained Earnings (Quarterly) (USD)|Entrada Therapeutics Inc Treasury Stock (Quarterly) (USD)|Entrada Therapeutics Inc EV to Revenues|Entrada Therapeutics Inc EV to Earnings|Entrada Therapeutics Inc EV to Free Cash Flow|Entrada Therapeutics Inc EV to Assets (Quarterly)|Entrada Therapeutics Inc PS Ratio|Entrada Therapeutics Inc PE Ratio|Entrada Therapeutics Inc Price to Book Value|Entrada Therapeutics Inc PEG Ratio|Entrada Therapeutics Inc Debt to Equity Ratio|Entrada Therapeutics Inc Dividend Yield|Entrada Therapeutics Inc Shareholder Yield (TTM)|Entrada Therapeutics Inc Percent of Shares Outstanding Short|Entrada Therapeutics Inc Total Receivables (Quarterly) (USD)|Entrada Therapeutics Inc Total Payables (Quarterly) (USD)|Entrada Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Entrada Therapeutics Inc Return on Invested Capital|Entrada Therapeutics Inc Quality Ratio Score|Entrada Therapeutics Inc Momentum Score|Entrada Therapeutics Inc Beta (1Y)|Entrada Therapeutics Inc Sustainable Growth Rate (TTM)|Entrada Therapeutics Inc Institutional Investor Ownership Percentage|Entrada Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Entrada Therapeutics Inc Total Employees (Annual)|Entrada Therapeutics Inc EPS Diluted (Quarterly) (USD)|Entrada Therapeutics Inc Shares Outstanding|Entrada Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Entrada Therapeutics Inc Ordinary Shares Number (Quarterly)|Entrada Therapeutics Inc Payout Ratio|Entrada Therapeutics Inc Quick Ratio (Quarterly)|Entrada Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Entrada Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Entrada Therapeutics Inc Effective Tax Rate (TTM)|Entrada Therapeutics Inc Return on Equity|Entrada Therapeutics Inc Net Income (TTM) (USD)|Entrada Therapeutics Inc Revenue (TTM) (USD)|Entrada Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Entrada Therapeutics Inc Revenue (Quarterly) (USD)|Entrada Therapeutics Inc Gross Profit (Quarterly) (USD)|Entrada Therapeutics Inc SG&A Expense (Quarterly) (USD)|Entrada Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Entrada Therapeutics Inc Net Income (Quarterly) (USD)|Entrada Therapeutics Inc Net Interest Income (Quarterly) (USD)|Entrada Therapeutics Inc Price (USD)|Entrada Therapeutics Inc Total Return Price (USD)|Entrada Therapeutics Inc Enterprise Value (USD)|Entrada Therapeutics Inc 30-Day Average Daily Volume|Entrada Therapeutics Inc 1 Year Price Returns (Daily)
new_adrs_0322_1335|TRDA|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_adrs_0322_1335|TRDA||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_adrs_0322_1335|TRDA||5|5|121.666666667|121.666666667|0|121.666666667|0|121.666666667|121.666666667|121.666666667|0|121.666666667|121.666666667|0|0|0|0|0|0|0|1.45283018868|0|0|1.45833333333|0|15.25|0|121.666666667|121.666666667|0|0|0|0|0|30|152.333333333|92|152.333333333|21|0|121.666666667|0|0|152.333333333|0|0|0|0|0|0|0|0|152.333333333|152.333333333|152.333333333|152.333333333|1.45833333333|1.45833333333|1.45833333333|1.46268656716|0
new_adrs_0322_1335|TRDA||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|0|0|0|0|53|0|0|96|0|8|0|3|3|0|0|0|0|0|1|3|2|3|6|0|3|0|0|3|0|0|0|0|0|0|0|0|3|3|3|3|96|96|96|67|0
new_adrs_0322_1335|TRDA||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_adrs_0322_1335|TRDA|202009|202009|202009||||||||||||||||||||||||||||||||||20.4759||-0.3414||||||-0.3414|||||||||1.273|-6.99|-6.99|-0.017|||||
new_adrs_0322_1335|TRDA|202012|202012|202012|39.949|39.045||3.037||85.017|3.359|81.658||-41.49|-42.511|||||||||||||||1.602|0|||||||20.4759||-0.4236|||28.3124|||-0.4236|||||||||1.997|-8.673|-8.673|-0.02|||||
new_adrs_0322_1335|TRDA|202106|202106|202106|137.636|136.947||5.087||202.528|4.536|197.992||-59.014|-60.792|||||||||||||||1.881|0||||||||78||||28.3124||||||||||||||||||||
new_adrs_0322_1335|TRDA|202109|202109|202109|123.525|122.172||5.901||204.986|7.158|197.828||-72.591|-75.222|||||||||||||||2.278|0|||||||28.3124|98|-0.5097|||28.3124|||-0.5097|||||||||3.851|-14.43|-14.43|-0.066|||||
new_adrs_0322_1335|TRDA|202110|202109|202109||||||||||||||||||||||0||0|||||||||3.4019||||29.8874||||||||||||||||||23.95|23.95|593.6312||
new_adrs_0322_1335|TRDA|202111|202109|202109||||||||||||||||||||||0||2.7916|||||||||19.8115||||31.2129||||||||||||||||||29.78|29.78|807.3482||
new_adrs_0322_1335|TRDA|202112|202112|202112|298.7|291.064||6.261||7.115|6.719|0.396||298.718|-93.669||||||||1.7895|||0||5.3954||0.706|0.003|||||||31.2243|114|-0.89|31.2243||31.2243|||-0.89||||-48.54|||||6.098|-18.447|-18.447|0.013|17.12|17.12|243.496|224277.3|
new_adrs_0322_1335|TRDA|202201|202112|202112|||||||||||||||||||1.1571|||0||6.1403|||||||||||||||||||||||||||||||11.07|11.07|54.589|163048.9|
new_adrs_0322_1335|TRDA|202202|202112|202112|||||||||||||||||||1.269|||0||7.2383|||||||||||||31.2515||||||||||||||||||12.13|12.13|88.0167|91341.7333|
new_adrs_0322_1335|TRDA|202203|202203|202203|||||||||||||||||||1.0305|||0|||||||||||||||||||||||||||||||||9.85|9.85|16.7633|102260.1667|